Genistein and Galantamine Combinations Decrease β-Amyloid Peptide (1–42)–Induced Genotoxicity and Cell Death in SH-SY5Y Cell Line: an In Vitro and In Silico Approach for Mimic of Alzheimer’s Disease
Willian Orlando Castillo Ordoñez, Nilza Velasco Palomino, Catarina Satie Takahashi, Silvana Giuliatti
Topics & Concepts
NeuroprotectionGenisteinViability assayGalantaminePharmacologyAmyloid betaBiologyChemistryBiochemistryMedicineCellDonepezilInternal medicineEndocrinologyPeptideDementiaDiseaseAlzheimer's disease research and treatmentsPhytoestrogen effects and researchCholinesterase and Neurodegenerative Diseases